Medicare Agency to End Some Demonstration Projects, Cancel $2 Generic Drug Initiative
The Centers for Medicare and Medicaid Services plans to terminate four demonstration projects by the end of 2025, closing out ...
Indian generic drugs linked to deaths in US? Trade group slams study blaming desi pharma
A study found Indian generics sold in the US between 2009-2018 linked to a 54% higher risk of serious side effects compared ...
Prices of diabetes drug empagliflozin falls by 80-90% as generics enter market
Mankind Pharma, Alkem Laboratories, Glenmark are some of the companies to have launched, making the drug affordable to most ...
The Financial Express2d
Empagliflozin generic to be sold at 90% discount, expecting 50% volume growth: Mankind’s MD Rajeev Juneja
Glenmark and Alkem Labs launched the generic version as well as its Fixed Dose Combination (FDCs) of Empagliflozin in India.